People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cerimon Pharmaceuticals, Inc. | — | Pharmaceuticals | Seed | $3.7M | $8.9M | 2010 |
Denise P. Pollard-Knight at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Denise P. Pollard-Knight on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ansbert Gadicke | 1 | 7 |
| Robert Adelman | 1 | 5 |
| James H. Welch | 1 | 3 |
| Vaughn Kailian | 1 | 3 |
| James S. Shannon | 1 | 2 |
| Gary Patou | 1 | 2 |
| Paul Hastings | 1 | 2 |
| Samuel P. Wertheimer | 1 | 2 |
| James P. Shannon | 1 | 1 |
| Paul P. Hastings | 1 | 1 |
| Ansbert P. Gadicke | 1 | 1 |
| Matthew J. Meyer | 1 | 1 |
| Vaughn P. Kailian | 1 | 1 |
| Gary P. Patou | 1 | 1 |
| Denise Pollard-Knight | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.